Course Instructions
Instructions to Complete the Course:
- Review information below, as desired
- When ready, select the "Course" tab
- Click "Access" to begin
- You are required to view the course video
- Viewing or downloading the Additional Resources is optional, however, you must open the section and click "Mark As Complete"
- You will now have access to the "Post Exam"
- Complete the 5 quiz questions to conclude your learning experience. There is no required passing grade
- Upon completion, you are required to complete a course evaluation
- When all components are complete, you will have access to your CME certificate, and, if eligible, you will have MOC credits awarded
- Any MOC credits awarded will be reported to ABPM on your behalf
- You may view your CME or MOC credits in your transcript as well as retrieve your CME certificate
About the Course
ACPM received a grant from the Centers for Disease Control and Prevention (CDC) Office of Health Systems Collaboration to develop a course on the CDC's 6|18 Initiative. It provides an overview of the initiative, lists the barriers that keep providers from applying the interventions and offers recommendations for implementation at the individual and systems levels. Through case studies, the course addresses the role of providers in implementing the initiative.
Faculty
Jocelyn Carter, MD, MPH
Dr. Jocelyn Carter is a practicing internal medicine hospitalist at Massachusetts General Hospital (MGH; Boston, MA) and a 2017 Aetna Foundation Fellow in Healthcare Innovation within the MGH Healthcare Transformation Lab. Clinically prepared in internal medicine and leadership/ preventive medicine at Dartmouth Hitchcock Medical Center (Lebanon, NH), Jocelyn is passionate about experiential learning, transformational change via scalable, cost-efficient initiatives and the use of outcomes research and healthcare information technology to drive the redesign of patient-centered care and healthcare innovation. As a recent awardee of a 2017 Partners Healthcare Center for Population Health Delivery System Innovation Implementation Grant, Jocelyn and her team are studying the impact of 30-day patient-community health worker pairings at the time of hospital discharge on health care outcomes in high risk populations. She is an editor of the Society of Hospital Medicine Clinical Quick Talks and is a regular reviewer for esteemed academic journals.
Catherine J. Livingston, MD, MPH, FAAFP, FACPM
Dr. Catherine Livingston is double-boarded in Family Medicine and Public Health & Preventive Medicine. She is faculty at Oregon Health & Science University and practices as a family physician in the inpatient and outpatient setting as well as teaching residents and medical students. She also serves as the Associate Medical Director of the Health Evidence Review Commission which sets the benefit package for the Medicaid population in Oregon. Dr. Livingston performs evidence reviews to translate evidence into policy and has special foci on evidence-based medicine, obesity, integrating public health and health care, and opioid policy.
Toyosi O. Morgan, MD, MPH, MBA
Dr. Toyosi Morgan is a Medical Director in the Chief Medical Officer Organization, Healthcare Services Segment of Humana Inc. In this role, she helps manage the strategy and operations for Physician Value-Based (accountable care) relationships and well as advancing clinical care into the home. Prior to this, she completed a two year experience within the Humana Executive Physician Immersion Program to gain a understanding of the industry through the lens of network development and contracting, healthcare innovation, marketing, corporate strategy, grievance/appeals and local market operations. She maintains active patient care in a local primary care facility. Prior to joining Humana, Dr. Morgan was the program director for the preventive medicine residency at Emory University. During her preventive medicine training, she helped certify nine primary care practices as NCQA Level 3 patient-centered medical homes, initially at Grady Health System and subsequently at Emory Healthcare. She also established a lifestyle medicine clinical practice for patients with chronic diseases seeking to make meaningful behavior change with their nutrition, physical activity, mindfulness, sleep and relationships. This clinical model’s objectives were to help patients with stable chronic diseases improve outcomes and reduce health care costs.
Outcome Objectives
- Describe the 6|18 initiative including the evidence-based interventions developed to address the six health conditions
- Identify the barriers that prevent physicians from utilizing the 6|18 interventions
- Describe the role of physicians in implementing the initiative in various practice settings
- Discuss potential opportunities for collaboration with key stakeholders
- Identify behavioral economic strategies to advance the provider adoption of the 6|18 interventions
- Describe provider implementation strategies to include 6|18 interventions within emerging payment models
- Identify innovative strategies for leveraging team-based approaches for utilizing the 6|18 interventions
- Identify positive health outcomes of patients when providers utilize the interventions within the 6|18 Initiative
About the CDC's 6|18 Initiative
With the 6|18 Initiative, the CDC is partnering with health care purchasers, payers, and providers to improve health and control health care costs. The CDC provides these partners with rigorous evidence about high-burden health conditions and associated interventions to inform their decisions to have the greatest health and cost impact. This initiative offers proven interventions that prevent chronic and infectious diseases by increasing their coverage, access, utilization, and quality. Additionally, it aligns evidence-based preventive practices with emerging value-based payment and delivery models. The CDC is targeting six common and costly health conditions–tobacco use, high blood pressure, healthcare-associated infections, asthma, unintended pregnancies, and diabetes—and, initially, 18 proven specific interventions that formed the starting point of discussions with purchasers, payers, and providers. The number of interventions may fluctuate over time.